For the research context it is key for understanding why amylin analogs do not develop tolerance with chronic use (unlike many other anti-obesity molecules)
In January 2025, PRAC began its review of medicines containing semaglutide, after noting that two recent observational studies suggested an elevated risk of patients developing NAION
Reta will reduce your overall caloric intake the risk is that you also eat less protein, which accelerates muscle loss
Valdecantos P, Rada P, Ghosh S, Rondinone CM, Valverde AM
What Makes a Dessert GLP-1-Forward
In fact, we ran clinical trials with both oral semaglutide and oral tirzepatide, and the results looked no better than placebo for weight loss